AstraZeneca’s Imfinzi Gets Approval In Japan For Extensive-stage Small Cell Lung Cancer

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) announced Friday that its Imfinzi (durvalumab) has been approved in Japan for the treatment of patients with extensive-stage small cell lung cancer or ES-SCLC. SCLC is a highly aggressive, fast-growing form of lung cancer that typically recurs and progresses rapidly, despite initial response to... To keep reading about AstraZeneca’s Imfinzi Gets Approval In Japan For Extensive-stage Small Cell Lung Cancer, Click on the link. Seoul, Korea
http://dlvr.it/Rf3bY9

Comments

Post a Comment

Popular posts from this blog

Stock Alert: Moderna Jumps 16% As Covid Vaccine 94.1% Effective; To Apply For Emergency Use

Image
Financial world news, market analysis, investment scam prevention tips and more ✔️ Learn all there is to know about the asset management industry. This magazine is crafted specifically for those who are interested in diving into the global asset management world. (RTTNews) - Shares of Moderna, Inc. (MRNA) are rising more than 16% Monday morning after the company said it is planning to apply for U.S and European Emergency approval of its Covid-19 vaccine mRNA-1273, as its late study showed that the vaccine candidate is 94.1% effective to prevent the disease. The stock touched a new high of $150 this morning The company on Monday said it plans to apply for Emergency Use Authorization (EUA) from the U.S. FDA and conditional approval from the European Medicines Agency (EMA). The company also reported vaccine efficacy against severe Covid-19 was 100%. To keep reading about Stock Alert: Moderna Jumps 16% As Covid Vaccine 94.1% Effective; To Apply For Emergency Use, Click on the link. Seo...
Read more

Swiss Market Ends Higher Again

News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. (RTTNews) - After a flat start and a subsequently decent uptick, the Switzerland stock market briefly slipped into the red Friday morning, but managed to end the session marginally up despite swinging between gains and losses. The mood was a bit cautious amid rising virus cases and lockdown extensions in several parts of Europe. The benchmark SMI ended with a gain of 18 points or 0.16% at 11,116.81, after hitting a new 52-week high at 11,143.86. The SMI ended with a gain of 34.94 points or 0.32% on Thursday, after losing about 0.3% a session earlier. ABB, Partners Group, Credit Suisse and LafargeHolcim gained 1.2 to 1.7%. Shares of specialty chemicals company Sika gained about 1% after the firm said that it has acquired the flooring ...
Read more

Covid: Snap lockdown ordered in Australia's Brisbane

Image
News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. BRISBANE: More than two million people in Brisbane were ordered into a three-day lockdown Monday after a cluster of coronavirus cases was detected in Australia's third-biggest city. It is the second snap lockdown of Brisbane and the city's surrounds this year, coming after seven people tested positive for Covid-19 -- the first significant community outbreak in Australia in weeks. "This is the UK strain. It is highly infectious. Now we need to do this now to avoid a longer lockdown," Queensland state Premier Annastacia Palaszczuk said. "We've seen what's happened in other countries. I don't want to see that happen to Queensland, I don't want to see that happen to Australia." Schools, restaurants and ...
Read more